ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,993,000 | +431.7% | 23,200 | +49.8% | 0.13% | +600.0% |
| Q2 2018 | $751,000 | +299.5% | 15,488 | +221.9% | 0.02% | +260.0% |
| Q1 2018 | $188,000 | -41.1% | 4,811 | -60.0% | 0.01% | -28.6% |
| Q1 2017 | $319,000 | +3.9% | 12,037 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $307,000 | -51.1% | 12,037 | -30.6% | 0.01% | -50.0% |
| Q3 2016 | $628,000 | +6.4% | 17,350 | 0.0% | 0.01% | +7.7% |
| Q2 2016 | $590,000 | – | 17,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |